✦ScienexySCIENCE KNOWLEDGE LIBRARY
drug_safety · SCI-HUM-002-021

Basic Principles of Drug Safety

Introduces the scientific and practical principles used to reduce medicine-related harm, including quality assurance, appropriate use, contraindication assessment, adverse-event monitoring, and pharmacovigilance.

Explanation

Introduction

Drug safety is the field concerned with identifying, evaluating, preventing, and minimizing harm associated with medicinal products. No medicine is completely free from risk in every possible circumstance. Drug safety therefore requires reliable pharmaceutical quality, evidence-based selection, appropriate clinical use, monitoring, and continuous evaluation of new safety information.

Core principles

PrincipleDescription

Quality assurance

Medicines should meet appropriate standards for identity, strength, purity, quality, and manufacturing consistency.

Evidence-based use

Medicines should be used for indications supported by reliable scientific and clinical evidence.

Appropriate patient selection

Clinical decisions should consider relevant conditions, allergies, contraindications, age, and other patient-specific factors.

Awareness of interactions

Potential interactions with other medicines, foods, and relevant substances should be considered.

Monitoring

Treatment outcomes and relevant adverse effects should be evaluated according to clinical needs and applicable guidance.

Accurate information

Reliable labeling, patient information, and professional communication support safer medicine use.

Continuous safety surveillance

New information about adverse effects and medicine-related problems should be collected and evaluated.

Important safety concepts

ConceptDefinition

Adverse drug reaction

A harmful and unintended response associated with the use of a medicinal product.

Adverse event

An unfavorable medical occurrence following exposure to a medicinal product, which does not necessarily have a proven causal relationship with the product.

Medication error

A preventable event that may lead to inappropriate medicine use or patient harm.

Contraindication

A condition or situation in which a medicine should not be used because its risks are considered unacceptable.

Pharmacovigilance

The science and activities concerned with detecting, assessing, understanding, and preventing adverse effects or other medicine-related problems.

Medicine safety process

StageDescription

Before authorization

Preclinical and clinical investigations evaluate quality, safety, and evidence of therapeutic benefit.

Regulatory evaluation

Regulatory authorities assess the available evidence and determine whether a product may be authorized for specified uses.

After authorization

Safety monitoring continues because some adverse effects may be uncommon, delayed, or difficult to identify before wider use.

Signal detection and assessment

Potential safety signals are investigated to determine whether new evidence suggests a previously unrecognized risk.

Risk minimization

Appropriate regulatory, labeling, educational, or clinical measures may be introduced when necessary.

Factors influencing drug safety

  • Active ingredient and pharmaceutical formulation.

  • Medicine quality and storage conditions.

  • Patient age and physiological characteristics.

  • Genetic variation and drug metabolism.

  • Liver and kidney function.

  • Coexisting diseases.

  • Other medicines and relevant interactions.

  • Clinical indication and duration of treatment.

  • Accuracy of prescribing, dispensing, and administration processes.

Pharmacovigilance activities

  • Collection of suspected adverse reaction reports.

  • Evaluation of possible causal relationships.

  • Detection of safety signals.

  • Analysis of safety data from clinical and real-world sources.

  • Communication of new or updated safety information.

  • Implementation and evaluation of risk-minimization measures.

Safe medicine information

  • Use authoritative and current medicine information.

  • Check the active ingredient and product formulation.

  • Consider warnings, contraindications, and interactions.

  • Avoid relying on unsupported claims or unverified product information.

  • Seek qualified professional assessment when medicine-related concerns arise.

Common misconceptions

MisconceptionCorrection

A medicine is completely safe because it is legally authorized.

Authorization is based on an assessment of evidence for specified uses; ongoing monitoring remains necessary.

Every adverse event is caused by the medicine taken.

An adverse event may occur after exposure without being causally related to the medicine.

Drug safety evaluation ends after a medicine enters the market.

Post-authorization surveillance continues to identify and assess emerging safety information.

Example or application

Title

Post-Authorization Safety Monitoring

Scenario

A medicine has been authorized after appropriate scientific and regulatory evaluation.

Process

  • Healthcare professionals and other reporting systems collect information about suspected adverse reactions.

  • Safety specialists assess the quality and pattern of reports.

  • Potential signals are investigated using additional clinical and scientific evidence.

  • Regulatory authorities may update product information or introduce appropriate risk-minimization measures.

Learning point

Drug safety is a continuous process that extends beyond initial clinical testing and authorization.

Definition

Drug safety is the systematic evaluation, monitoring, and prevention of harmful effects and medicine-related problems throughout the development, authorization, and use of medicinal products.

Purpose

  • To introduce the major principles of medicine safety.

  • To explain the difference between adverse events and adverse drug reactions.

  • To describe the role of pharmacovigilance.

  • To identify factors that can influence medicine-related risk.

  • To explain why safety monitoring continues after regulatory authorization.

Importance

  • Helps prevent avoidable medicine-related harm.

  • Supports quality assurance and responsible clinical practice.

  • Improves detection of previously unrecognized adverse effects.

  • Strengthens public confidence through transparent safety monitoring.

  • Contributes to continuous improvement in pharmaceutical regulation.

Related Topics

  • SCI-HUM-002-014

  • SCI-HUM-002-020

  • SCI-HUM-002-022

  • SCI-HUM-002-024

Sources and verification

Sources are shown as provided in the project data. Not every source has yet been independently verified. Please report errors or missing citations.

Suggest a correction or source · More in Pharmacology